Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.

Pickles K, Kazda L, Barratt A, McGeechan K, Hersch J, McCaffery K.

PLoS One. 2020 Jan 15;15(1):e0227304. doi: 10.1371/journal.pone.0227304. eCollection 2020.

2.

Estimating the magnitude of cancer overdiagnosis in Australia.

Glasziou PP, Jones MA, Pathirana T, Barratt AL, Bell KJ.

Med J Aust. 2019 Dec 19. doi: 10.5694/mja2.50455. [Epub ahead of print]

PMID:
31858624
3.

Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review.

Kazda L, Bell K, Thomas R, McGeechan K, Barratt A.

BMJ Open. 2019 Nov 7;9(11):e032327. doi: 10.1136/bmjopen-2019-032327.

4.

Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.

Bach AC, Lo KS, Pathirana T, Glasziou PP, Barratt AL, Jones MA, Bell KJ.

Med J Aust. 2020 Jan;212(1):17-22. doi: 10.5694/mja2.50376. Epub 2019 Nov 6.

PMID:
31691294
5.

Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.

O'Keeffe M, Barratt A, Maher C, Zadro J, Fabbri A, Jones M, Moynihan R.

BMJ Open. 2019 Aug 24;9(8):e029532. doi: 10.1136/bmjopen-2019-029532.

6.

Overdiagnosis of left ventricular non-compaction in adults: the data tells the story.

Ross SB, McGeechan K, Barratt A, Semsarian C.

Eur Heart J. 2019 Oct 7;40(38):3206. doi: 10.1093/eurheartj/ehz535. No abstract available.

PMID:
31364715
7.

The association between induction of labour at 38 to 39 weeks pregnancy and indication for caesarean delivery: An observational study.

de Vries BS, McGeechan K, Barratt A, Tooher J, Wong E, Phipps H, Gordon A, Hyett JA.

Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):791-798. doi: 10.1111/ajo.13006. Epub 2019 Jul 9.

PMID:
31287155
8.

Framework for Estimating Indirect Costs in Animal Health Using Time Series Analysis.

Barratt AS, Rich KM, Eze JI, Porphyre T, Gunn GJ, Stott AW.

Front Vet Sci. 2019 Jun 18;6:190. doi: 10.3389/fvets.2019.00190. eCollection 2019.

9.

A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults.

Ross SB, Jones K, Blanch B, Puranik R, McGeechan K, Barratt A, Semsarian C.

Eur Heart J. 2019 May 29. pii: ehz317. doi: 10.1093/eurheartj/ehz317. [Epub ahead of print]

PMID:
31143950
10.

Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.

McCaffery K, Nickel B, Pickles K, Moynihan R, Kramer B, Barratt A, Hersch J.

BMJ Open. 2019 May 23;9(5):e026960. doi: 10.1136/bmjopen-2018-026960.

11.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Glasziou PP.

Med J Aust. 2019 Jun;210(11):525-525.e1. doi: 10.5694/mja2.50197. Epub 2019 May 22. No abstract available.

PMID:
31119741
12.

Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.

Nickel B, Semsarian C, Moynihan R, Barratt A, Jordan S, McLeod D, Brito JP, McCaffery K.

BMJ Open. 2019 Feb 5;9(2):e025820. doi: 10.1136/bmjopen-2018-025820.

13.

Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?

Bell KJL, Doust J, Glasziou P, Cullen L, Harris IA, Smith L, Buchbinder R, Barratt A.

Ann Intern Med. 2019 Feb 19;170(4):259-261. doi: 10.7326/M18-2645. Epub 2019 Feb 5. No abstract available.

PMID:
30716768
14.

Financial Vulnerability of Dairy Farms Challenged by Johne's Disease to Changes in Farm Payment Support.

Shrestha S, Vosough Ahmadi B, Barratt AS, Thomson SG, Stott AW.

Front Vet Sci. 2018 Dec 18;5:316. doi: 10.3389/fvets.2018.00316. eCollection 2018.

15.

Outcomes of induction of labour in nulliparous women at 38 to 39 weeks pregnancy by clinical indication: An observational study.

de Vries BS, Barratt A, McGeechan K, Tooher J, Wong E, Phipps H, Gordon A, Hyett JA.

Aust N Z J Obstet Gynaecol. 2019 Aug;59(4):484-492. doi: 10.1111/ajo.12930. Epub 2018 Dec 27.

PMID:
30588611
16.

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.

Carter SM, Barratt A, Doust J, Degeling C.

Ann Intern Med. 2018 Dec 4;169(11):823-824. doi: 10.7326/L18-0515. No abstract available.

PMID:
30508436
17.

Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.

Nickel B, Barratt A, McGeechan K, Brito JP, Moynihan R, Howard K, McCaffery K.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):867-874. doi: 10.1001/jamaoto.2018.1272.

18.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Buchbinder R, Carter SM, Dakin T, Donovan J, Elshaug AG, Glasziou PP, Maher CG, McCaffery KJ, Scott IA.

Med J Aust. 2018 Oct 15;209(8):332-334. No abstract available.

PMID:
30309305
19.

Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening.

Barratt A, Bell K, Jacklyn G.

J Am Coll Radiol. 2018 Oct;15(10):1360. doi: 10.1016/j.jacr.2018.06.030. No abstract available.

PMID:
30286894
20.

Knowledge of current abortion law and views on abortion law reform: a community survey of NSW residents.

Barratt AL, McGeechan K, Black KI, Hamblin J, de Costa C.

Aust N Z J Public Health. 2019 Feb;43(1):88-93. doi: 10.1111/1753-6405.12825. Epub 2018 Sep 10.

PMID:
30198605
21.

Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.

Nickel B, Howard K, Brito JP, Barratt A, Moynihan R, McCaffery K.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):887-896. doi: 10.1001/jamaoto.2018.1694.

22.

Renaming low risk conditions labelled as cancer.

Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K.

BMJ. 2018 Aug 12;362:k3322. doi: 10.1136/bmj.k3322. No abstract available.

PMID:
30100549
23.

Correction: A framework for estimating society's economic welfare following the introduction of an animal disease: The case of Johne's disease.

Barratt AS, Arnoult MH, Ahmadi BV, Rich KM, Gunn GJ, Stott AW.

PLoS One. 2018 Aug 9;13(8):e0202253. doi: 10.1371/journal.pone.0202253. eCollection 2018.

24.

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.

Degeling C, Barratt A, Aranda S, Bell R, Doust J, Houssami N, Hersch J, Sakowsky R, Entwistle V, Carter SM.

BMJ Open. 2018 Jun 14;8(6):e021174. doi: 10.1136/bmjopen-2017-021174.

25.

A framework for estimating society's economic welfare following the introduction of an animal disease: The case of Johne's disease.

Barratt AS, Arnoult MH, Ahmadi BV, Rich KM, Gunn GJ, Stott AW.

PLoS One. 2018 Jun 6;13(6):e0198436. doi: 10.1371/journal.pone.0198436. eCollection 2018. Erratum in: PLoS One. 2018 Aug 9;13(8):e0202253.

26.

Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.

Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K.

BMC Cancer. 2018 Mar 2;18(1):242. doi: 10.1186/s12885-018-4152-9.

27.

Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic Cardiomyopathy.

Bonner C, Spinks C, Semsarian C, Barratt A, Ingles J, McCaffery K.

J Genet Couns. 2018 Sep;27(5):1040-1048. doi: 10.1007/s10897-018-0218-8. Epub 2018 Feb 22.

PMID:
29468337
28.

Population attributable fractions of perinatal outcomes for nulliparous women associated with overweight and obesity, 1990-2014.

Cheney K, Farber R, Barratt AL, McGeechan K, de Vries B, Ogle R, Black KI.

Med J Aust. 2018 Feb 19;208(3):119-125.

PMID:
29438637
29.

Intraoperative use of adjuvants for opioid sparing: a cross-sectional survey of anaesthetists in teaching hospitals in South Australia.

Thiruvenkatarajan V, Watts R, Barratt A, Pazvash P, Howell S, Van Wijk RM.

Anaesth Intensive Care. 2018 Jan;46(1):138-130. No abstract available.

30.

"Thank You for Giving Me a Voice!" A Longitudinal Evaluation of Patients' Experience of Partnering With Students in an Australian Medical School.

Ivory KD, Luscombe G, Klein LA, Barratt A.

J Med Educ Curric Dev. 2017 Mar 15;4:2382120517692776. doi: 10.1177/2382120517692776. eCollection 2017 Jan-Dec.

31.

Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.

Thomas ET, Del Mar C, Glasziou P, Wright G, Barratt A, Bell KJL.

BMC Cancer. 2017 Dec 2;17(1):808. doi: 10.1186/s12885-017-3808-1. Review.

32.

Reform of the National Screening Mammography Program in France.

Barratt A, Jørgensen KJ, Autier P.

JAMA Intern Med. 2018 Feb 1;178(2):177-178. doi: 10.1001/jamainternmed.2017.5836. Review. No abstract available.

PMID:
29084317
33.

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.

Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, Houssami N, Dhillon H, McCaffery K.

BMJ Open. 2017 Oct 6;7(10):e016246. doi: 10.1136/bmjopen-2017-016246.

34.

Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.

Jacklyn G, Morrell S, McGeechan K, Houssami N, Irwig L, Pathmanathan N, Barratt A.

Breast. 2018 Feb;37:170-178. doi: 10.1016/j.breast.2017.08.005. Epub 2017 Sep 5.

PMID:
28882419
35.

Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices.

Parker L, Carter S, Williams J, Pickles K, Barratt A.

Eur J Cancer. 2017 Nov;85:1-5. doi: 10.1016/j.ejca.2017.07.056. Epub 2017 Sep 4.

PMID:
28881246
36.

"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials.

Dear RF, McGeechan K, Barnet MB, Barratt AL, Tattersall MHN.

J Natl Compr Canc Netw. 2017 Sep;15(9):1131-1139. doi: 10.6004/jnccn.2017.7012.

PMID:
28874598
37.

Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.

Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, Barratt A.

Breast Cancer Res Treat. 2017 Dec;166(3):843-854. doi: 10.1007/s10549-017-4443-x. Epub 2017 Aug 19.

PMID:
28822001
38.

What is overdiagnosis and why should we take it seriously in cancer screening?

Carter SM, Barratt A.

Public Health Res Pract. 2017 Jul 26;27(3). pii: 2731722. doi: 10.17061/phrp2731722.

39.

Words do matter: a systematic review on how different terminology for the same condition influences management preferences.

Nickel B, Barratt A, Copp T, Moynihan R, McCaffery K.

BMJ Open. 2017 Jul 10;7(7):e014129. doi: 10.1136/bmjopen-2016-014129. Review.

40.

Impact of extending screening mammography to older women: Information to support informed choices.

Jacklyn G, Howard K, Irwig L, Houssami N, Hersch J, Barratt A.

Int J Cancer. 2017 Oct 15;141(8):1540-1550. doi: 10.1002/ijc.30858. Epub 2017 Jul 10. Erratum in: Int J Cancer. 2017 Dec 15;141(12 ):E8.

41.

Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.

Nickel B, Brito JP, Barratt A, Jordan S, Moynihan R, McCaffery K.

Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.

PMID:
28322617
42.

Overview of guidelines on breast screening: Why recommendations differ and what to do about it.

Jørgensen KJ, Kalager M, Barratt A, Baines C, Zahl PH, Brodersen J, Harris RP.

Breast. 2017 Feb;31:261-269. doi: 10.1016/j.breast.2016.08.002. Epub 2016 Oct 4. Review.

PMID:
27717717
43.

A definition and ethical evaluation of overdiagnosis: response to commentaries.

Carter SM, Doust J, Degeling C, Barratt A.

J Med Ethics. 2016 Nov;42(11):722-724. doi: 10.1136/medethics-2016-103822. Epub 2016 Aug 29.

PMID:
27573152
44.

Performing (heterosexual) femininity: female agency and role in sexual life and contraceptive use - a qualitative study in Australia.

Kelly M, Inoue K, Barratt A, Bateson D, Rutherford A, Richters J.

Cult Health Sex. 2017 Feb;19(2):240-255. doi: 10.1080/13691058.2016.1214872. Epub 2016 Aug 23.

PMID:
27550536
45.

A definition and ethical evaluation of overdiagnosis.

Carter SM, Degeling C, Doust J, Barratt A.

J Med Ethics. 2016 Nov;42(11):705-714. doi: 10.1136/medethics-2015-102928. Epub 2016 Jul 8.

PMID:
27402883
46.

Doctors' experience of the contraceptive consultation: a qualitative study in Australia.

Kelly M, Inoue K, Black KI, Barratt A, Bateson D, Rutherford A, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):119-125. doi: 10.1136/jfprhc-2015-101356. Epub 2016 May 12.

47.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

48.

Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users.

Inoue K, Kelly M, Barratt A, Bateson D, Rutherford A, Black KI, Stewart M, Richters J.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):128-134. doi: 10.1136/jfprhc-2014-101132. Epub 2016 Mar 3.

49.

Walking the tightrope: communicating overdiagnosis in modern healthcare.

McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, Barratt A, Sheridan S, Moynihan R, Waller J, Brodersen J, Pickles K, Edwards A.

BMJ. 2016 Feb 5;352:i348. doi: 10.1136/bmj.i348. No abstract available.

PMID:
26850726
50.

Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection.

Ingles J, Burns C, Barratt A, Semsarian C.

Circ Cardiovasc Genet. 2015 Dec;8(6):852-9. doi: 10.1161/CIRCGENETICS.115.001093. Review. No abstract available.

PMID:
26671970

Supplemental Content

Loading ...
Support Center